merck oral glp-1 GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Race is on for oral

Foods rich in GSH almonds, avocado, broccoli & turmeric

The healing process is particularly interesting in two closely related tissues: muscle and tendon

Dehydration is a particular concern, as reduced food intake often means reduced fluid intake, and gastrointestinal side effects such as vomiting or diarrhoea can further deplete fluid and electrolyte balance

Overview Representatives from ANZCA, the Gastroenterological Society of Australia, the Australian Diabetes Society, and the National Association of Clinical Obesity Services and Australian and New Zealand Metabolic and the Obesity Surgery Society have developed revised recommendations for patients taking GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists prior to anaesthesia or sedation

The research also focused on the medication experience

Most people feel effects within 15 to 30 minutes, with the highest risk window in the first 12 hours